Aptamers. Oligonucleotide or peptide molecules that bind to a specific target molecule. I’m almost certain that this is the one big medical advances that is going to come out of this pandemic.
You already see companies including BioNTech doing something similar by deploying mRNA to treat early MS which is an autoimmune disease. These short segments of mRNA get coded into what are the equivalent of aptamers.
These aptamers can then bind to specific target molecules with a certain degree of specificity depending on the proteins encoded. That could include autoimmune antibodies or other disease causing molecules.
It may very well be the mechanism that causes some long COVID patients to have symptomatic improvement because the spike protein (though a much larger protein) is acting like an aptamer to reset the autoimmune presentation of self-antigens.
Of course this is all theory (and I’m no expert) but I hope this kind of molecular development becomes much more targeted and specific and becomes a potential alternative to steroids and current autoimmune treatments which are like blunt hammers.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
I’m realizing that in modern medicine there are these conditions that are viewed as unpopular siblings in certain disciplines. For instance in rheumatology it might be Sjogrens and in neurology it might be POTS.
Those who study more well defined and understood conditions scoff at the poor research in these areas, question the clinical practices, and often label patients with those conditions as difficult or likely falsely attributing symptoms that might not be real.
I wonder if it was the same many years ago when there were other conditions that weren’t well understood. If doctors had the same gall and presumptions. Or maybe back then there was a much more prevalent acceptance that knowledge was limited.